179 related articles for article (PubMed ID: 9804340)
41. Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair-deficient/cancer-prone xeroderma pigmentosum group C patients.
Fréchet M; Warrick E; Vioux C; Chevallier O; Spatz A; Benhamou S; Sarasin A; Bernerd F; Magnaldo T
Oncogene; 2008 Sep; 27(39):5223-32. PubMed ID: 18469853
[TBL] [Abstract][Full Text] [Related]
42. Structural and mutational analysis of the xeroderma pigmentosum group D (XPD) gene.
Frederick GD; Amirkhan RH; Schultz RA; Friedberg EC
Hum Mol Genet; 1994 Oct; 3(10):1783-8. PubMed ID: 7849702
[TBL] [Abstract][Full Text] [Related]
43. Chromosomal localization of three repair genes: the xeroderma pigmentosum group C gene and two human homologs of yeast RAD23.
van der Spek PJ; Smit EM; Beverloo HB; Sugasawa K; Masutani C; Hanaoka F; Hoeijmakers JH; Hagemeijer A
Genomics; 1994 Oct; 23(3):651-8. PubMed ID: 7851894
[TBL] [Abstract][Full Text] [Related]
44. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
45. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
Nishigori C; Fujisawa H; Uyeno K; Kawaguchi T; Takebe H
Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):146-50. PubMed ID: 1814424
[TBL] [Abstract][Full Text] [Related]
46. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients.
Carreau M; Quilliet X; Eveno E; Salvetti A; Danos O; Heard JM; Mezzina M; Sarasin A
Hum Gene Ther; 1995 Oct; 6(10):1307-15. PubMed ID: 8590735
[TBL] [Abstract][Full Text] [Related]
47. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene.
Broughton BC; Berneburg M; Fawcett H; Taylor EM; Arlett CF; Nardo T; Stefanini M; Menefee E; Price VH; Queille S; Sarasin A; Bohnert E; Krutmann J; Davidson R; Kraemer KH; Lehmann AR
Hum Mol Genet; 2001 Oct; 10(22):2539-47. PubMed ID: 11709541
[TBL] [Abstract][Full Text] [Related]
48. Effects of XPD mutations on ultraviolet-induced apoptosis in relation to skin cancer-proneness in repair-deficient syndromes.
Queille S; Drougard C; Sarasin A; Daya-Grosjean L
J Invest Dermatol; 2001 Nov; 117(5):1162-70. PubMed ID: 11710928
[TBL] [Abstract][Full Text] [Related]
49. Loss of Function Variants in the XPC Causes Severe Xeroderma Pigmentosum in Three Large Consanguineous Families.
Nawal W; Ullah A; Ullah U; Farrakh K; Ahmad F; Khan H; Ahmad GS; Khan B; Ansar M; Kalsoom UE; Ahmad W
Klin Padiatr; 2022 May; 234(3):123-129. PubMed ID: 34544175
[TBL] [Abstract][Full Text] [Related]
50. Clinical and cellular ionizing radiation sensitivity in a patient with xeroderma pigmentosum.
Arlett CF; Plowman PN; Rogers PB; Parris CN; Abbaszadeh F; Green MH; McMillan TJ; Bush C; Foray N; Lehmann AR
Br J Radiol; 2006 Jun; 79(942):510-7. PubMed ID: 16714754
[TBL] [Abstract][Full Text] [Related]
51. Splice site mutations in a xeroderma pigmentosum group A patient with delayed onset of neurological disease.
States JC; Myrand SP
Mutat Res; 1996 Aug; 363(3):171-7. PubMed ID: 8765158
[TBL] [Abstract][Full Text] [Related]
52. The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts.
Emmert S; Kobayashi N; Khan SG; Kraemer KH
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2151-6. PubMed ID: 10681431
[TBL] [Abstract][Full Text] [Related]
53. Xeroderma pigmentosum variant heterozygotes show reduced levels of recovery of replicative DNA synthesis in the presence of caffeine after ultraviolet irradiation.
Itoh T; Linn S; Kamide R; Tokushige H; Katori N; Hosaka Y; Yamaizumi M
J Invest Dermatol; 2000 Dec; 115(6):981-5. PubMed ID: 11121129
[TBL] [Abstract][Full Text] [Related]
54. The cloned human DNA excision repair gene ERCC-1 fails to correct xeroderma pigmentosum complementation groups A through I.
van Duin M; Vredeveldt G; Mayne LV; Odijk H; Vermeulen W; Klein B; Weeda G; Hoeijmakers JH; Bootsma D; Westerveld A
Mutat Res; 1989 Mar; 217(2):83-92. PubMed ID: 2918869
[TBL] [Abstract][Full Text] [Related]
55. Mutations in the XPD gene leading to xeroderma pigmentosum symptoms.
Kobayashi T; Kuraoka I; Saijo M; Nakatsu Y; Tanaka A; Someda Y; Fukuro S; Tanaka K
Hum Mutat; 1997; 9(4):322-31. PubMed ID: 9101292
[TBL] [Abstract][Full Text] [Related]
56. Complete restoration of normal DNA repair characteristics in group F xeroderma pigmentosum cells by over-expression of transfected XPF cDNA.
Yagi T; Matsumura Y; Sato M; Nishigori C; Mori T; Sijbers AM; Takebe H
Carcinogenesis; 1998 Jan; 19(1):55-60. PubMed ID: 9472693
[TBL] [Abstract][Full Text] [Related]
57. Xeroderma pigmentosum genes and melanoma risk.
Paszkowska-Szczur K; Scott RJ; Serrano-Fernandez P; Mirecka A; Gapska P; Górski B; Cybulski C; Maleszka R; Sulikowski M; Nagay L; Lubinski J; Dębniak T
Int J Cancer; 2013 Sep; 133(5):1094-100. PubMed ID: 23436679
[TBL] [Abstract][Full Text] [Related]
58. Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons.
Kuschal C; DiGiovanna JJ; Khan SG; Gatti RA; Kraemer KH
Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19483-8. PubMed ID: 24218596
[TBL] [Abstract][Full Text] [Related]
59. Aberrant splicing and truncated-protein expression due to a newly identified XPA gene mutation.
Sato M; Nishigori C; Yagi T; Takebe H
Mutat Res; 1996 Feb; 362(2):199-208. PubMed ID: 8596539
[TBL] [Abstract][Full Text] [Related]
60. Biochemical and structural domain analysis of xeroderma pigmentosum complementation group C protein.
Bunick CG; Miller MR; Fuller BE; Fanning E; Chazin WJ
Biochemistry; 2006 Dec; 45(50):14965-79. PubMed ID: 17154534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
